Among the top 20 signatures identified from GSEA, several cancer‐related signatures, including the CCA signature and EGFR & KRAS signaling signatures, were significantly enriched in both cohorts (Figure 3A). The gene discussed is KRAS; the disease is cholangiocarcinoma.